X-ray irradiation reversed motor deficits after brain injury
Low dose ionising radiation reduced lesion size and reversed motor deficits in traumatic brain injury and ischemic stroke mice.
List view / Grid view
Low dose ionising radiation reduced lesion size and reversed motor deficits in traumatic brain injury and ischemic stroke mice.
The new study’s findings suggest that CRS can be treated with an IL-6 receptor antibody that has a short half-life.
3 January 2024 | By Eurofins DiscoverX
Watch this webinar to discover functional cell-based assays for characterizing novel therapeutics & biosimilars targeting cytokines in inflammation & oncology.
Research suggests immune and non-immune cells can be reprogrammed by changing how nutrients are used.
Cytokine multiplex assays allow researchers to measure multiple cytokines, chemokines and growth factors from one small sample.
In this ebook are articles on immune checkpoint inhibitors and enhancing CAR T-cell therapies.
Researchers have found that the GDF15 cytokine could have beneficial effects on the metabolism and reduce obesity.
This exclusive ebook takes an in-depth look at recent developments in the field of cancer immunotherapy, with expert interviews exploring how researchers are advancing next-generation cell therapies into the clinic.
Researchers have established a list of compounds that effect cytokine storms that could reduce mortality in COVID-19 patients.
4 January 2022 | By SomaLogic
Watch our on-demand one-hour session to discover groundbreaking work to advance precision medicine for Castleman disease.
Save time by measuring 48 immune factors, generating more than 1,800 data points from a single plate, with a small sample volume.
Researchers have revealed that the immune system of obese mice treated with TSLP released lipids through sebaceous glands.
A new conjugate vaccine has shown promise at protecting mice against the effects of cytokines associated with asthma.
5,000+ drug target reagents for antibody, small molecule drug discovery and development, including immune checkpoints, cytokines and kinases.
Dr James Woody discusses off-patent indications for anti-TNF to address unmet patient needs in pain, inflammation and beyond.